13F HOLDINGS REPORT
Altium Capital Management LP
Quarter ended Q4 2024 · Filed February 13, 2025 · Accession 0001420506-25-000357
Total Value
$352.6M
Positions
67
Other Managers
0
Confidential Omitted
No
Holdings (67)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ADMA BIOLOGICS INC | ADMA | 1,395,000 | $23.9M | 6.79% |
| 2 | VERA THERAPEUTICS INC | VERA | 432,000 | $18.3M | 5.18% |
| 3 | SAREPTA THERAPEUTICS INC | SRPT | 127,000 | $15.4M | 4.38% |
| 4 | ZEVRA THERAPEUTICS INC | ZVRA | 1,850,000 | $15.4M | 4.38% |
| 5 | ESTABLISHMENT LABS HLDGS INC | ESTA | 305,000 | $14.1M | 3.99% |
| 6 | ESTABLISHMENT LABS HLDGS INC | ESTA | 300,000 | $13.8M | 3.92% |
| 7 | SCHOLAR ROCK HLDG CORP | SRRK | 300,000 | $13.0M | 3.68% |
| 8 | EDWARDS LIFESCIENCES CORP | EW | 165,000 | $12.2M | 3.46% |
| 9 | XENON PHARMACEUTICALS INC | XENE | 288,000 | $11.3M | 3.20% |
| 10 | SOLENO THERAPEUTICS INC | SLNO | 250,000 | $11.2M | 3.19% |
| 11 | CAPRICOR THERAPEUTICS INC | CAPR | 714,000 | $9.9M | 2.79% |
| 12 | RXSIGHT INC | RXST | 285,000 | $9.8M | 2.78% |
| 13 | MERIT MED SYS INC | 589889104 | 100,000 | $9.7M | 2.74% |
| 14 | BIOHAVEN LTD | BHVN | 250,000 | $9.3M | 2.65% |
| 15 | INSMED INC | INSM | 132,000 | $9.1M | 2.58% |
| 16 | REZOLUTE INC | RZLT | 1,694,000 | $8.3M | 2.35% |
| 17 | EVOLUS INC | EOLS | 685,000 | $7.6M | 2.14% |
| 18 | INTRA-CELLULAR THERAPIES INC | 46116X101 | 75,000 | $6.3M | 1.78% |
| 19 | ARGENX SE | ARGX | 10,000 | $6.2M | 1.74% |
| 20 | GLAUKOS CORP | GKOS | 40,000 | $6.0M | 1.70% |
| 21 | RESMED INC | RSMDF | 26,000 | $5.9M | 1.69% |
| 22 | VIKING THERAPEUTICS INC | VKTX | 146,000 | $5.9M | 1.67% |
| 23 | EXACT SCIENCES CORP | 30063P105 | 100,000 | $5.6M | 1.59% |
| 24 | PULMONX CORP | LUNG | 815,000 | $5.5M | 1.57% |
| 25 | COMPASS PATHWAYS PLC | CMPS | 1,424,400 | $5.4M | 1.53% |
| 26 | CATALYST PHARMACEUTICALS INC | CPRX | 255,000 | $5.3M | 1.51% |
| 27 | CONTINEUM THERAPEUTICS INC | CTNM | 334,000 | $4.9M | 1.39% |
| 28 | SYNDAX PHARMACEUTICALS INC | SNDX | 370,000 | $4.9M | 1.39% |
| 29 | SAVARA INC | SVRA | 1,579,000 | $4.8M | 1.37% |
| 30 | AVADEL PHARMACEUTICALS PLC | G29687103 | 452,475 | $4.8M | 1.35% |
| 31 | CORBUS PHARMACEUTICALS HLDGS | CRBP | 385,000 | $4.5M | 1.29% |
| 32 | ARROWHEAD PHARMACEUTICALS IN | ARWR | 230,257 | $4.3M | 1.23% |
| 33 | ANTERIS TECHNOLOGIES GLOBAL | AVR | 737,000 | $4.1M | 1.17% |
| 34 | PROFOUND MED CORP | PROF | 485,000 | $3.6M | 1.03% |
| 35 | XTANT MED HLDGS INC | 98420P308 | 7,415,413 | $3.3M | 0.93% |
| 36 | SKYE BIOSCIENCE INC | SKYE | 1,139,000 | $3.2M | 0.91% |
| 37 | ORIC PHARMACEUTICALS INC | ORIC | 355,000 | $2.9M | 0.81% |
| 38 | TG THERAPEUTICS INC | TGTX | 95,000 | $2.9M | 0.81% |
| 39 | NEKTAR THERAPEUTICS | NKTR | 3,000,000 | $2.8M | 0.79% |
| 40 | KEROS THERAPEUTICS INC | KROS | 175,000 | $2.8M | 0.79% |
| 41 | ANAPTYSBIO INC | ANABV | 206,200 | $2.7M | 0.77% |
| 42 | IMMUNITYBIO INC | IBRX | 1,060,000 | $2.7M | 0.77% |
| 43 | LEXEO THERAPEUTICS INC | LXEO | 405,000 | $2.7M | 0.76% |
| 44 | TERNS PHARMACEUTICALS INC | TERN | 475,000 | $2.6M | 0.75% |
| 45 | REVOLUTION MEDICINES INC | RVMDW | 60,000 | $2.6M | 0.74% |
| 46 | ESSA PHARMA INC | 29668H708 | 1,428,000 | $2.6M | 0.73% |
| 47 | ALPHATEC HLDGS INC | ATEC | 264,562 | $2.4M | 0.69% |
| 48 | LARIMAR THERAPEUTICS INC | LRMR | 505,000 | $2.0M | 0.55% |
| 49 | ONKURE THERAPEUTICS INC | OKUR | 218,386 | $1.9M | 0.53% |
| 50 | ALPHA COGNITION INC | ACOG | 275,000 | $1.6M | 0.46% |
| 51 | LARIMAR THERAPEUTICS INC | LRMR | 396,000 | $1.5M | 0.43% |
| 52 | PROQR THRAPEUTICS N V | N71542109 | 575,000 | $1.5M | 0.43% |
| 53 | VERU INC | VERU | 2,028,534 | $1.3M | 0.37% |
| 54 | UNICYCIVE THERAPEUTICS INC | UNCY | 1,473,000 | $1.2M | 0.33% |
| 55 | ENVVENO MEDICAL CORPORATION | NVNO | 310,000 | $936,200 | 0.27% |
| 56 | BICYCLE THERAPEUTICS PLC | BCYC | 40,352 | $564,928 | 0.16% |
| 57 | PROMIS NEUROSCIENCES INC | PMN | 581,395 | $551,046 | 0.16% |
| 58 | FULCRUM THERAPEUTICS INC | FULC | 111,812 | $525,516 | 0.15% |
| 59 | KARYOPHARM THERAPEUTICS INC | KPTI | 740,000 | $500,462 | 0.14% |
| 60 | CYTOMX THERAPEUTICS INC | CTMX | 467,491 | $481,516 | 0.14% |
| 61 | XENON PHARMACEUTICALS INC | XENE | 9,400 | $368,480 | 0.10% |
| 62 | PERSPECTIVE THERAPEUTICS INC | CATX | 92,224 | $294,195 | 0.08% |
| 63 | BETTER CHOICE CO INC | SRXH | 118,459 | $278,379 | 0.08% |
| 64 | ANAPTYSBIO INC | ANABV | 18,326 | $242,636 | 0.07% |
| 65 | QUOIN PHARMACEUTICALS LTD | QNRX | 282,249 | $183,659 | 0.05% |
| 66 | CELLECTAR BIOSCIENCES INC | CLRB | 215,000 | $64,285 | 0.02% |
| 67 | APPLIED THERAPEUTICS INC | 03828A101 | 56,100 | $48,033 | 0.01% |